Q3 2020 Holdings
Filed 2020-11-16 | 93 holdings | $236.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $85.0M | 2,265,762 | 35.9% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $30.0M | 700,000 | 12.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $22.4M | 2,067,302 | 9.5% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $22.4M | 325,000 | 9.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $19.6M | 796,428 | 8.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $19.3M | 125,000 | 8.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $17.8M | 250,000 | 7.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $10.5M | 40,000 | 4.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $4.9M | 422,167 | 2.1% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $2.5M | 175,000 | 1.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $213.4K | 2,442,297 | 0.1% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $167.4K | 500,000 | 0.1% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $166.5K | 3,379,373 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $91.9K | 2,640,177 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $76.7K | 1,400,000 | 0.0% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $74.9K | 500,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $69.5K | 2,514,546 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $66.9K | 6,000,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $61.3K | 450,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $57.6K | 1,637,951 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $56.3K | 1,866,108 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $56.3K | 500,000 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $55.7K | 500,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $53.7K | 1,397,700 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $53.6K | 1,150,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $51.5K | 1,537,807 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $50.5K | 5,000,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $50.2K | 993,185 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $45.7K | 275,000 | 0.0% |
| Viela BIO Inc(VIE) | COM | 926613100 | $44.5K | 1,585,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $43.8K | 450,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $38.0K | 500,000 | 0.0% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $36.0K | 971,770 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $35.5K | 2,500,000 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $35.4K | 693,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $34.0K | 8,500,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $32.5K | 500,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $31.3K | 1,368,550 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $30.0K | 2,134,966 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $26.5K | 859,550 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $25.5K | 275,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $25.1K | 300,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $23.4K | 700,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $18.5K | 130,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $16.6K | 225,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $15.7K | 189,092 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $15.5K | 120,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $15.3K | 500,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR)Call | COM | 16383L106 | $13.7K | 250,000 | 0.0% |
| Pliant Therapeutics, Inc(PLRX) | COM | 729139105 | $13.6K | 611,409 | 0.0% |